Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Ryoki Hara »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ryoji Yoshida < Ryoki Hara < Ryoko Sakai  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000537 (2012) Toshihiko Shinoki [Japon] ; Ryoki Hara ; Utako Kaneko ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shumpei YokotaSafety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
000620 (2013) Yutaka Inaba [Japon] ; Remi Ozawa ; Chie Aoki ; Tomoyuki Imagawa ; Masaaki Mori ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Saito ; Shumpei YokotaRadiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
000B01 (2014) Chie Aoki ; Yutaka Inaba [Japon] ; Hyonmin Choe ; Utako Kaneko ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Mari S. Oba ; Shumpei Yokota ; Tomoyuki SaitoDiscrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
000B20 (2015) Shumpei Yokota [Japon] ; Masako Kikuchi ; Tomo Nozawa ; Taichi Kanetaka ; Tomomi Sato ; Kazuko Yamazaki ; Nodoka Sakurai ; Ryoki Hara ; Masaaki MoriPathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
001387 (2019) Tomo Nozawa [Japon] ; Kenichi Nishimura [Japon] ; Asami Ohara [Japon] ; Ryoki Hara [Japon] ; Shuichi Ito [Japon]Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
002805 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Ryoki Hara" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Ryoki Hara" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Ryoki Hara
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021